Invention Grant
- Patent Title: Use of inhibitors of bruton's tyrosine kinase (BTK)
-
Application No.: US16536058Application Date: 2019-08-08
-
Publication No.: US10653696B2Publication Date: 2020-05-19
- Inventor: Joseph J. Buggy , Gwen Fyfe , Lee Honigberg , David J. Loury
- Applicant: Pharmacyclics LLC
- Applicant Address: US CA Sunnyvale
- Assignee: Pharmacyclics LLC
- Current Assignee: Pharmacyclics LLC
- Current Assignee Address: US CA Sunnyvale
- Agency: Foley Hoag LLP
- Main IPC: A61K31/519
- IPC: A61K31/519 ; A61K31/195 ; A61K31/436 ; A61K31/454 ; A61K31/475 ; A61K31/573 ; A61K31/606 ; A61K31/675 ; A61K31/69 ; A61K31/704 ; A61K31/7076 ; A61K45/06 ; A61K9/48 ; A61K47/12 ; A61K47/10 ; A61K9/00 ; A61K47/20 ; A61K47/36 ; A61K47/14 ; A61K47/38 ; A61K47/26 ; A61K31/4184 ; A61K31/4745 ; A61K31/7032 ; A61K39/395 ; C07D487/04 ; A61K31/337 ; A61K31/437 ; A61K31/664 ; A61K9/06
Abstract:
Disclosed herein are methods for treating a cancer comprising: a. administering a Btk inhibitor to a subject sufficient to result in an increase or appearance in the blood of a subpopulation of lymphocytes defined by immunophenotyping; b. determining the expression profile of one or more biomarkers from one or more subpopulation of lymphocytes; and c. administering a second agent based on the determined expression profile.
Information query
IPC分类:
